Source: Annual Congress 2003 - Acute exacerbations of COPD
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Lampron, J. La Forge, J. Plante, M. Simon (Ste-Foy, Canada). Community-acquired pneumonia (CAP) in chronic obstructive pulmonary disease (COPD). Eur Respir J 2003; 22: Suppl. 45, 2134

Member's Comments

No comment yet.

Related content which might interest you: Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Does the condition of chronic obstructive pumonary disease (COPD) have a prognostic benefit in patients with community-acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 338s Year: 2003 Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB) Source: Eur Respir J 2006; 28: Suppl. 50, 395s Year: 2006 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020 Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Mycoplasma pneumoniae infection and acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Infection as a comorbidity of COPD Source: Eur Respir J 2010; 35: 1209-1215 Year: 2010 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Prognosis after non-invasive ventiltation (NIV) for chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011 Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 518s Year: 2005 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Bacterial infection-a common cause of acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Use of antibiotics in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Severe exacerbations of chronic obstructive pulmonary disease (COPD) due to Pseudomonas aeruginosa: resistance to common antibiotics Source: Eur Respir J 2001; 18: Suppl. 33, 540s Year: 2001 Awareness of chronic obstructive pulmonary disease (COPD) in Portugal Source: Eur Respir J 2007; 30: Suppl. 51, 126s Year: 2007 Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002 Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001 A study of exacerbations by Gram-negative organisms in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007